The management of patients with hair loss requires a customized plan. Diagnosis, prognosis, psychosocial impact, treatment options, and patient preference are key determinants. This article discusses current agents for the treatment of three commonly encountered nonscarring alopecias: male- and female-pattern hair loss, telogen effluvium, and alopecia areata. Algorithmic approaches to management are provided.
Division of Dermatology, University of British Columbia, and Vancouver Coastal Health Research Institute, 835 West 10th Avenue, Vancouver, BC V5Z 4E8, Canada
Corresponding author
Dr. Shapiro is a consultant for Pfizer, Inc., and Merck & Co, Inc.
ABSTRACT